A long-standing Fortune 500 company, ABB is a Swedish-Swiss company that works in the markets of electrification, motion, robotics and automation.
Swedish employees generally rely on a broad sense of teamwork and individual responsibility to get things done. Swedish office behaviour can differ quite a bit compared to other countries, with for example a low level of hierarchy, casual atmosphere, and a consensus culture.
Credits: Margareta Bloom Sandebäck/Imagebank.sweden.se
This half-day training event on September 30, 2026, is tailored for researchers involved in developing advanced therapy medicinal products (ATMPs), including cell and gene therapies.
Held at Bistro Merge in The Spark building at Medicon Village, Lund, the training will cover important topics such as funding pathways, protecting research results, and how early scientific choices impact future development, manufacturing, and clinical feasibility.
The event is organized by ATMP Path2Patient, an EU co-funded initiative uniting stakeholders in southern Sweden to support the ATMP ecosystem and accelerate the development and commercialization of new therapies.
Open to researchers at all levels without the need for a defined project, the training also provides an overview of regional support and resources available in the ATMP field.
The format includes the training session followed by lunch and networking at Restaurant Inspira.
Practical Info: - Date & Time: 30 September 2026, 08:30 – 12:45 - Location: Bistro Merge, The Spark building, Medicon Village, Scheeletorget 1, Lund - Language: English - Registration Deadline: 28 September 2026
[This content is generated by AI. Event and information is sourced from another organisation.]